Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading SNTA News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.32%14.918.4%$220.21m
SHPGShire PLC Sponsored ADR
-1.38%164.110.3%$168.35m
PRGOPerrigo Co. Plc
0.03%76.483.6%$128.67m
MNKMallinckrodt Plc
3.37%48.108.8%$126.12m
JAZZJazz Pharmaceuticals Plc
-3.26%124.422.2%$91.43m
UTHRUnited Therapeutics Corporation
0.42%153.4417.3%$91.08m
ENDPEndo International Plc
-2.05%12.906.3%$75.86m
ICPTIntercept Pharmaceuticals, Inc.
-0.98%114.6719.7%$63.79m
PCRXPacira Pharmaceuticals, Inc.
3.41%40.9511.1%$58.24m
PRXLPAREXEL International Corporation
-0.14%70.908.2%$46.38m
SGYPSynergy Pharmaceuticals, Inc.
-1.84%6.4114.6%$45.70m
HZNPHorizon Pharma plc
-1.52%16.8611.5%$44.70m
PTLAPortola Pharmaceuticals, Inc.
-0.66%25.429.1%$41.94m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.98%118.6510.5%$39.76m
MDCOMedicines Company
-3.51%36.0216.4%$32.90m

Company Profile

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.